Philips Healthcare announced that CX50 xMatrix, the first portable ultrasound with Philips' Live 3-D transesophageal echo (TEE), now offers 2-D intracardiac echo (ICE) capability. The CX50 xMatrix with available Live 3-D TEE and ICE was first shown in Paris at the EuroPCR in May.
Montage Healthcare Solutions will demonstrate the latest enhancements to its search-driven radiology business intelligence and clinical quality analytics tools, at the upcoming SIIM Annual Meeting. The latest version of Montage Search and Analytics includes numerous usability and performance enhancements, and a new clinical quality analytics package. Works-in-progress that will also be shown to gather user feedback, include Montage Signal, and a new Radiology Resident dashboard. Montage Signal, first shown as a prototype at RSNA 2012, flags report inconsistencies that degrade clinical quality and impact reimbursement. The new resident dashboard helps residency program directors and radiology residents ensure case volumes meet minimum requirements that are now mandated by the ACGME Resident Review Committee.
The Canvys Healthcare team has launched its new Image Systems 6MP (megapixel) display with LED backlights, and the quality control (QC) Vue browser-based, zero-footprint QC tool for mobile devices and displays. The new 30-inch widescreen, color display features LED backlights that provide high brightness and contrast.
In June, the Philips Radiology Experience Tour hit the road to provide healthcare professionals with an opportunity to ...
The results of the first (of three planned) annual low-dose computed tomography (LDCT) lung cancer screening examinations from the National Lung Screening Trial (NLST) were recently published in the New England Journal of Medicine.
Sensus Healthcare has received clearance from the U.S. Food and Drug Administration (FDA) to treat Keloids with the SRT-100. The SRT-100 is an alternative to surgery in treating non-melanoma skin cancer and now is approved to treat keloids caused by surgery or injury. Leading dermatologists and oncologists have found the SRT-100 superficial radiotherapy system to be a choice for their patients who are not good surgical candidates. Sensus Healthcare has reintroduced superficial radiotherapy (SRT) to the global clinical community as a viable, safe, and cost-effective modality to treat non-melanoma skin cancers and keloids in hospitals and private practice settings.
Varian Medical Systems received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Varian’s diagnostic X-ray image processing workstation that combines radiographic/fluoroscopy (RF) and digital radiography (DR) capabilities on one platform. Varian’s Nexus DRF Digital X-Ray Imaging System has the ability to interface with a variety of image receptors, including CCD cameras and commercially available flat-panel image detectors.
This summer, the Philips Radiology Experience Tour has been bringing Philips imaging modalities directly to the ...
Aortic arch pulse wave velocity, a measure of arterial stiffness, is a strong independent predictor of disease of the vessels that supply blood to the brain, according to a new study published in the June issue of the journal Radiology.
Syntermed Inc. has been awarded 510(k) clearance for Emory Cardiac Toolbox version 4.0. "One of the many things that makes Emory Toolbox 4.0 different is SmartReport, the first-ever, cloud-based nuclear cardiology reporting tool using decision support,” said Michael Lee, CEO, Syntermed Inc. The decision support system that powers SmartReport is called Syntermed IDS and will allow diagnosticians to perform faster, more accurate nuclear cardiology reports from single photon emission computed tomography (SPECT) and positron emission tomography (PET) heart scans.
Intermountain Healthcare, a Utah-based nonprofit system of 22 hospitals and 185 clinics, is compiling the cumulative radiation patients receive from about 220,000 higher-dose procedures and imaging exams each year, starting with exams performed in the last quarter of 2012. That information is now readily available to both physicians and patients.
Unavoidable damage caused to the heart and lungs by radiotherapy treatment of tumors in the chest region can be limited by the administration of an ACE inhibitor, a drug commonly used in the treatment of cardiovascular disease, a group of Dutch researchers have found. 
M-Files Inc. said Elekta is deploying M-Files in the cloud to more effectively manage quality documentation and related processes for several key aspects of its global business.
Magnetic resonance imaging (MRI) measurements of atrophy in an important area of the brain are an accurate predictor of multiple sclerosis (MS), according to a new study published online in the journal Radiology. According to the researchers, these atrophy measurements offer an improvement over current methods for evaluating patients at risk for MS.
Fujifilm recently expanded its enterprise imaging portfolio with Synapse Pathology, the company’s newly acquired and ...
InSightec Ltd. announced that the U.S. Centers for Medicare & Medicaid Services (CMS), a federal agency within the U.S. Department of Health and Human Services (HHS), has created a new billing code for magnetic resonance (MR) guided focused ultrasound treatment of pain palliation of metastatic bone lesions and has established a Medicare payment rate for hospital outpatient departments.
At an event held at Hospital for Special Surgery, GE Healthcare introduced Mavric SL, a novel magnetic resonance (MR) imaging technique designed to address the growing clinical need to more accurately image soft tissue and bone in patients with MR conditional-labeled implants, such as joint replacements and other instrumentation. According to a Hospital for Special Surgery study published in The Journal of Bone & Joint Surgery, MR imaging can detect inflammation of the joint lining (synovitis) in patients with metal-on-metal hip implants long before symptoms appear, allowing for a more conclusive diagnosis and effective planning for follow-up care.
New hope for cancer patients is building in North Texas as construction begins on the $105 million Texas Center for Proton Therapy, the first proton therapy center in the Dallas-Fort Worth Metroplex. The center, spearheaded by healthcare leaders Texas Oncology, The U.S. Oncology Network and McKesson Specialty Health, will have capacity to treat more than 100 patients per day when it opens in 2016.
Facilitating collaboration between radiologic technologists and radiologists to improve patient care, communication and quality improvement is one of the key safety recommendations outlined in a new white paper from the ASRT Foundation.
The U.S. Food and Drug Administration (FDA) granted 510(k) clearance to Medical Imaging Electronics (MiE) and Nuclear Imaging Services (NIS) ECAT Scintron. It is the only upgrade path available to the Siemens ECAT 47, ECAT HR+, and ECAT Accel positron emission tomography (PET) systems. The ACSII and SUN workstation are removed from the system and replaced with new PC-based technology that provides new and existing users of the ECAT series PET systems access to faster processing speeds, new acquisition protocols and parts availability. With improved reliability and longevity, the ECAT Scintron redefines the life cycle of dedicated PET systems in the U.S. market.
Planmed Verity is designed to find subtle extremity fractures during the first visit to the clinic. Planmed Verity Extremity Scanner provides fast, 3-D imaging at the point of care. It is intended for pre- and postoperative imaging, and it has better resolution and patient adaptability and uses a significantly lower dose of radiation than full-body computed tomography (CT). Planmed Verity also allows for weight-bearing imaging of the extremities.
The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) have published a joint guideline on radiation therapy after prostatectomy for patients with and without evidence of prostate cancer recurrence. The 81-page document represents an intensive collaboration among experts in the radiation oncology and urology fields.
Positron Corp. announced the release of the PosiRx 3000-Series, its latest pharmacy automation systems. The PosiRx 3000-Series are the first systems to automate and encompass the complete compounding process, from generator elution to dose distribution, of multiple diagnostic SPECT agents in an environment engineered to be ISO Class 5 and USP 797 compliant. Designed for facilities dispensing as many as 300 patient-specific doses per day, the PosiRx 3000-Series will benefit providers and patients by enabling unit dose radiopharmaceuticals to be prepared more cost effectively and accurately than previously possible.